The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
 
Satoshi Kobayashi
Honoraria - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Eisai; Lilly; Otsuka; Taiho Pharmaceutical; Takeda; Yakult Honsha; Zymeworks
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo/UCB Japan (Inst); Eisai (Inst); Incyte (Inst); Lilly (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Taito Fukushima
No Relationships to Disclose
 
Makoto Ueno
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo/UCB Japan; Incyte; J-pharma; MSD; Mylan; Novartis; Ono Pharmaceutical; SERVIER; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Novocure
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chiome Bioscience (Inst); Chugai Pharma (Inst); Delta-Fly Pharma (Inst); Eisai (Inst); Incyte (Inst); J-pharma (Inst); JPH Clinical Development (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Makoto Chuma
No Relationships to Disclose
 
Kazushi Numata
No Relationships to Disclose
 
Kota Tsuruya
No Relationships to Disclose
 
Yoshitaka Arase
No Relationships to Disclose
 
Shunji Hirose
No Relationships to Disclose
 
Tatehiro Kagawa
Honoraria - Abbvie; Chugai Pharma; Eisai; Gilead Sciences
Research Funding - Abbvie (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst)
 
Nobuhiro Hattori
No Relationships to Disclose
 
Tsunemasa Watanabe
No Relationships to Disclose
 
Kotaro Matsunaga
No Relationships to Disclose
 
Haruki Uojima
No Relationships to Disclose
 
Hisashi Hidaka
No Relationships to Disclose
 
Chika Kusano
No Relationships to Disclose
 
Manabu Morimoto
Research Funding - AstraZeneca Japan (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Eisai (Inst); MSD (Inst)
 
Shin Maeda
No Relationships to Disclose